BioCentury
ARTICLE | Financial News

Valeant prices $1B in notes

November 20, 2010 1:27 AM UTC

Valeant Pharmaceuticals International Inc. (NYSE:VRX; TSX:VRX) raised $1 billion in a bumped-up offering of 6.875% senior unsecured notes due 2018. Valeant priced the offering late Thursday after prop...